Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060548 · ClinicalTrials.gov registry record
Role of Novel ILR in the Management of PVCs
A clinical trial of Myocarditis and PVC - Premature Ventricular Contraction, sponsored by Kansas City Heart Rhythm Research Foundation.
- Recruiting
- Registry status
- 50
- Enrollment target
- 6
- Study locations
NCT06060548 is a study of Myocarditis and PVC - Premature Ventricular Contraction that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 50 participants, below the 378-participant average among 5 other Myocarditis trials with a reported enrollment target (87% lower). The trial reports 6 study locations across 2 states.
The verdict
NCT06060548, a study of Myocarditis and PVC - Premature Ventricular Contraction, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.
Conditions Studied
Interventions
- OTHER Monitoring of patients presenting with PVCs
Study Locations (6)
Missouri
- Centerpoint Medical Center Clinic - Independence
- Centerpoint Medical Center - Independence
- Research Medical Center Clinic - Kansas City
- Research Medical Center - Kansas City
Kansas
- Kansas City Heart Rhythm Institute - Roe Clinic - Overland Park
- Overland Park Regional Medical Center - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06060548
The ClinicalTrials.gov registry entry for NCT06060548 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 5 other Myocarditis trials with a reported enrollment target (87% lower). The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myocarditis appearing as the primary indexed condition, and to 1 intervention - of which Monitoring of patients presenting with PVCs is the first listed.
NCT06060548 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Kansas.
Frequently Asked Questions
What is clinical trial NCT06060548 about?
NCT06060548 is a clinical study titled "Role of Novel ILR in the Management of PVCs". This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.
What is the current status of trial NCT06060548?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-04-20. Estimated completion is 2025-12.
What conditions does trial NCT06060548 study?
This clinical trial studies the following conditions: Myocarditis, PVC - Premature Ventricular Contraction.
What interventions are being tested in trial NCT06060548?
The interventions under investigation include: Monitoring of patients presenting with PVCs (OTHER).
Who is sponsoring clinical trial NCT06060548?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06060548 being conducted?
This trial has 6 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocarditis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
RECRUITING
-
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
RECRUITING · Phase 4
-
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
ACTIVE NOT RECRUITING
-
Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
COMPLETED · Phase 2
-
Evaluation of MyoStrain™ in Clinical Practice
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.